Here are three highlights:
1. The patents strengthen VTI’s suite of patents covering its modular device design.
2. Currently, VTI possess 28 patents and patent-pending assets.
3. VTI’s InterFuse System features intraoperative assembly technology, which creates a large implant footprint via a minimally invasive approach.
More articles on devices:
Device tax repeal likely: 5 thoughts from AdvaMed President Scott Whitaker
OrthAlign taps Andy Turner to run operations in Australia and New Zealand — 4 key notes
Global bone growth stimulators market — Spinal fusion segment led in 2016
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
